Verrica Pharmaceuticals Inc. VRCA
NASDAQ · United States · Health Technology
$4.67-0.13 (-2.69%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.62 | -0.39 | -60.0% | $5.86M | +2.2% | -7.8%$5.51→$5.08 |
| Q1 2026 | 2026-05-12 | -0.45 | -0.60 | +25.0% | — | — | -0.4%$7.40→$7.37 |
| Q4 2025 | 2026-03-11 | -0.51 | -0.64 | +20.3% | — | — | +2.8%$5.98→$6.15 |
| Q3 2025 | 2025-11-14 | 0.05 | -1.15 | +104.3% | — | — | -3.6%$3.87→$3.73 |
| Q4 2024 | 2025-03-11 | -2.01 | -2.42 | +16.9% | — | — | — |
| Q1 2024 | 2024-05-13 | -4.40 | -4.40 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.